Dinner Time 2: Effect of Delayed Eating or Sleeping on Metabolism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-15

Study Completion Date

2025-06-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examines the acute impact of eating an "early" versus "late" dinner. "Early" and "late" will be customized to individuals based on the individuals' own circadian rhythms. Healthy adults will have the adults' circadian rhythm assessed by measuring the adults' dim light melatonin onset (DLMO). Based on the timing of DLMO, participants will be randomized to eating dinner before DLMO or after DLMO. The investigators will also compare the effects of delaying sleep relative to dinner time. Participants will eat meals in the laboratory and have serial plasma samples collected to examine profiles of free fatty acids, glucose, insulin, triglycerides, and oxidation of dietary fat.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Late Dinner on Nocturnal Metabolism

NCT03525717

Healthy

COMPLETED NA

Effect of Skipping Breakfast on Metabolic Function

NCT02093572

Skipping Breakfast Circadian Rhythms

COMPLETED NA

Effect of Timed-Restricted Eating on Metabolic Health

NCT06061042

Obesity Non-Alcoholic Fatty Liver Disease Insulin Resistance

RECRUITING NA

ChronoMet: Metabolic and Inflammatory Effects of Eating Timing and Quantity

NCT06161337

Healthy Volunteers

RECRUITING NA

The Influence of Time-Restricted Eating in Patients With Metabolic Syndrome

NCT04057339

Metabolic Syndrome Pre-Diabetes

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity is a worldwide health problem. Recent studies suggest that the timing of meals may be critically important for weight control and cardiovascular health. Consuming calories later in the day is associated with greater risks of obesity, metabolic syndrome, and cardiovascular disease. Interventional diet studies also show more effective weight loss with early, rather than later eating. The investigators conducted a randomized crossover study comparing the metabolic effect of a "routine" dinner (RD,18:00) with that of an isocaloric "late" dinner (LD, 22:00) in 20 healthy volunteers. The investigators recently published results of this study, which the investigators now refer to as "Dinner Time 1". Relative to RD, LD increased post-dinner glucose peak by \~18% and lowered palmitate oxidation by \~10%. However, it is still unclear whether LD-induced impaired metabolic dysfunction is caused by eating at the "wrong" time relative to the body's central circadian clock, or it is caused by eating too close to bedtime, when sleep reduces metabolic demands.

To address this question, the investigators are now enlarging the scope of the present study, which the investigators now refer to as "Dinner Time 2". In Dinner Time 2, the investigators will examine the impacts of early dinner, late dinner, and the impact of delaying sleep after late dinner. The investigators will compare (1) the impact of early dinner time with later dinner time relative to DLMO with a routine sleep time; and (2) the impact of routine bedtime with late bedtime with a fixed late dinner time.

The investigators will examine the nocturnal and next-morning metabolic profile in a 3-arm randomized crossover study of healthy volunteers:

Arm 1: Early Dinner (dinner at DLMO-3, sleep at DLMO+2) Arm 2: Late Dinner (dinner at DLMO+1, sleep at DLMO+2) Arm 3: Late Dinner/Late Sleep (dinner at DLMO+1, sleep at DLMO+6)

The investigators will use serial blood sampling to assess the metabolic response to meals, and use an ingested stable isotope \[(2H31)palmitate\] tracer to calculate the oxidation of dietary lipid eaten at the different times.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Late Dinner + Late Sleep first

Participants will be served dinner and a stable isotope of palmitate to measure fat oxidation, at a late dinner time (DLMO+1h) followed by delayed bedtime (DLMO+6h). This arm will cross-over to the other 2 arms in random order.

Group Type EXPERIMENTAL

Early dinner

Intervention Type BEHAVIORAL

Dinner at DLMO-3, sleep at DLMO+2

Late Dinner

Intervention Type BEHAVIORAL

Dinner at DLMO+1, sleep at DLMO+2

Late Dinner + Late Sleep

Intervention Type BEHAVIORAL

Dinner at DLMO+1, sleep at DLMO+6

Early Dinner first

Participants will be served dinner and a stable isotope of palmitate to measure fat oxidation, at an early dinner time (DLMO-3h) followed by a sleep study (DLMO+2h). This arm will cross-over to the other 2 arms in random order.

Group Type EXPERIMENTAL

Early dinner

Intervention Type BEHAVIORAL

Dinner at DLMO-3, sleep at DLMO+2

Late Dinner

Intervention Type BEHAVIORAL

Dinner at DLMO+1, sleep at DLMO+2

Late Dinner + Late Sleep

Intervention Type BEHAVIORAL

Dinner at DLMO+1, sleep at DLMO+6

Late Dinner first

Participants will be served dinner and a stable isotope of palmitate to measure fat oxidation, at a late dinner time (DLMO+1h) followed by a sleep study (DLMO+2h). This arm will cross-over to the other 2 arms in random order.

Group Type EXPERIMENTAL

Early dinner

Intervention Type BEHAVIORAL

Dinner at DLMO-3, sleep at DLMO+2

Late Dinner

Intervention Type BEHAVIORAL

Dinner at DLMO+1, sleep at DLMO+2

Late Dinner + Late Sleep

Intervention Type BEHAVIORAL

Dinner at DLMO+1, sleep at DLMO+6

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early dinner

Dinner at DLMO-3, sleep at DLMO+2

Intervention Type BEHAVIORAL

Late Dinner

Dinner at DLMO+1, sleep at DLMO+2

Intervention Type BEHAVIORAL

Late Dinner + Late Sleep

Dinner at DLMO+1, sleep at DLMO+6

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy male and female adult volunteers, age 18-30
* BMI 18-30 kg/m2
* Accustomed to a bedtime before 1:00 A.M. or having mid-sleep on free days (MSF) earlier than 5 A.M. from the Munich Chronotype Questionnaire (MCTQ) (to exclude extreme late chronotypes)

Exclusions:

* Sleep disorder including insomnia, sleep apnea, circadian rhythm disorder, restless leg syndrome, narcolepsy, shift work sleep disorder
* Gastroesophageal reflux disease that affects ability to tolerate a dinner close to bed time.
* Chronic use of sedative hypnotics, anxiolytics, opiates
* Use of medications that can affect circadian rhythm (beta blockers, melatonin)
* Active smoking (may interfere with metabolism and Clinical Research Unit (CRU) activities)
* Diabetes (type 1 or 2)
* HbA1c point of care \>= 6.5%
* Kidney disease
* Any known history of an inherited metabolic disorder
* Pregnant or lactating female (pregnancy test will be required)
* Professional or collegiate athlete
* Travel across \>1 time zone within a 3-month period before and during the protocol
* DLMO \> 24:00 will be excluded from the metabolic study visits

Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes